
KYKOF
Healthcare · Drug Manufacturers - Specialty & Generic · $8.53B market cap
$16.30+0.40 (+2.5%)Nov 13, 3:54 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 3, 2026 | After the close | 34.04 | 0.22 | -99.3% |
| May 7, 2026 | After the close | 27.46 | 0.15 | -99.5% |
| Feb 9, 2026 | After the close | 37.60 | 0.43 | -98.9% |
| Oct 30, 2025 | After the close | 28.91 | 0.21 | -99.3% |
| Jul 31, 2025 | After the close | 31.83 | 0.13 | -99.6% |
| May 1, 2025 | Before the open | 21.41 | 11.78 | -45.0% |
| Feb 6, 2025 | Before the open | 32.17 | 7.86 | -75.6% |
| Oct 31, 2024 | Before the open | 35.74 | 34.44 | -3.6% |
| Aug 1, 2024 | Before the open | 28.04 | 43.58 | +55.4% |
| May 7, 2024 | Before the open | 33.35 | 27.26 | -18.3% |
| Feb 7, 2024 | Before the open | 75.96 | 51.41 | -32.3% |
| Feb 6, 2023 | After the close | 27.10 | 8.11 | -70.1% |
| Nov 3, 2022 | After the close | 27.20 |
Kyowa Kirin Co., Ltd. engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally. The company offers Ziftomenib, an oral menin inhibitor for the treatment of adult relapsed or refractory and acute myeloid leukemia with a nucelophosmin1 mutation; and Lumicef for the treatment of palmoplantar pustulosis. It also develops KHK4083/AMG…
| 26.41 |
| -2.9% |
| Aug 3, 2022 | After the close | 26.00 | 35.31 | +35.8% |
| May 9, 2022 | After the close | 21.10 | 29.85 | +41.5% |
| Feb 6, 2022 | After the close | 21.10 | 36.18 | +71.5% |
| Oct 31, 2021 | After the close | 26.50 | 14.58 | -45.0% |
| Aug 2, 2021 | After the close | 25.30 | 22.62 | -10.6% |
| May 5, 2021 | After the close | 27.10 | 24.05 | -11.3% |
| Feb 3, 2021 | After the close | 21.50 | 17.76 | -17.4% |
| Oct 29, 2020 | After the close | 19.80 | 18.04 | -8.9% |
| Jul 29, 2020 | After the close | 20.10 | 25.98 | +29.3% |
| Apr 30, 2020 | After the close | — | 25.78 | — |
| Feb 4, 2020 | After the close | 12.50 | 20.09 | +60.7% |
| Oct 28, 2019 | After the close | 16.70 | 15.46 | -7.4% |
| Jul 31, 2019 | After the close | 62.50 | 74.05 | +18.5% |
| May 7, 2019 | After the close | 71.00 | 14.97 | -78.9% |
| Feb 5, 2019 | Before the open | — | 0.15 | — |
| Oct 29, 2018 | After the close | 13.10 | 24.01 | +83.3% |
| Jul 30, 2018 | After the close | 13.10 | 22.41 | +71.1% |
| May 7, 2018 | After the close | 30.20 | 40.20 | +33.1% |
| Feb 8, 2018 | Before the open | — | 0.38 | — |